Acadia Healthcare Company Inc
$ 17.17
-1.21%
24 Feb - close price
- Market Cap 1,552,928,000 USD
- Current Price $ 17.17
- High / Low $ 17.50 / 16.48
- Stock P/E 14.80
- Book Value 34.51
- EPS 1.16
- Next Earning Report 2026-02-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.04 %
- 52 Week High 42.85
- 52 Week Low 11.43
About
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
Analyst Target Price
$18.71
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-29 | 2025-04-29 | 2025-02-25 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 | 2023-07-27 | 2023-04-26 | 2023-02-27 |
| Reported EPS | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 | 0.75 | 0.7 |
| Estimated EPS | 0.67 | 0.7044 | 0.357 | 0.7146 | 0.9 | 0.87 | 0.81 | 0.79 | 0.89 | 0.86 | 0.71 | 0.75 |
| Surprise | 0.05 | 0.1256 | 0.043 | -0.0746 | 0.01 | 0.04 | 0.03 | 0.06 | 0.02 | 0.06 | 0.04 | -0.05 |
| Surprise Percentage | 7.4627% | 17.8308% | 12.0448% | -10.4394% | 1.1111% | 4.5977% | 3.7037% | 7.5949% | 2.2472% | 6.9767% | 5.6338% | -6.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2026-02-24 09:41:39
Acadia Healthcare (ACHC) is set to announce its earnings results this Wednesday morning. The company surpassed revenue expectations last quarter but missed full-year EPS and EBITDA guidance. Analysts anticipate revenue growth of 3.2% year-on-year for the upcoming quarter, and the stock is performing well compared to its peers in the healthcare providers & services sector.
2026-02-23 12:39:25
Guggenheim has reduced its price target for Acadia Healthcare (NASDAQ:ACHC) from $27 to $22 and maintained a Buy rating, citing regulatory headwinds such as New York Medicaid exclusions and California staffing ratios impacting its 2026 EBITDA estimate. The company faces a significant debt burden and challenges, with returning CEO Debbie Osteen expected to address these issues during the upcoming Q4 2025 earnings report. Despite a 57.65% drop in stock price over the past year, InvestingPro analysis suggests the company may be undervalued, with potential for growth through improved bed utilization and monetization events.
2026-02-23 12:06:46
Guggenheim has lowered its price target for Acadia Healthcare (NASDAQ:ACHC) to $22 from $27 while maintaining a Buy rating, citing regulatory headwinds such as New York Medicaid's exclusion of out-of-state referrals and California minimum staffing ratios. The firm also increased its leverage estimate and noted the company's significant debt burden. Despite these challenges, InvestingPro analysis suggests the stock may be undervalued, and returning CEO Debbie Osteen is expected to address operational issues.
2026-02-23 01:26:00
This article analyzes Acadia Healthcare Company Inc. (NASDAQ: ACHC), indicating strong near- and mid-term sentiment but a weak long-term outlook. It identifies an exceptional 78.4:1 risk-reward short setup and outlines specific institutional trading strategies, including long, breakout, and short positions with defined entry and exit points, and stop losses. The analysis also provides multi-timeframe signal analysis and access to real-time AI-generated signals for traders.
2026-02-23 00:29:47
Acadia Healthcare's CEO, Debbie Osteen, stated that the sale of its UK operations positions the company for significant domestic growth in 2021 and beyond. The company plans to add approximately 300 beds to existing facilities and open 4-5 new facilities through joint partnerships, while also expanding medication-assisted treatment and telehealth services. Analysts from Jefferies also view Acadia's future positively as a pure-play behavioral health provider in the US.
2026-02-20 15:31:40
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced its participation in three investor conferences in March 2026. The company will present at the Raymond James & Associates’ 47th Annual Institutional Investors Conference, the Leerink Partners 2026 Global Healthcare Conference, and the Barclays 28th Annual Global Healthcare Conference. Live webcasts and replays of these presentations will be available on Acadia's investor relations website.
